Skip to main content
Erschienen in: Pediatric Nephrology 5/2012

01.05.2012 | Editorial Commentary

Syndrome of inappropriate antidiuresis and cerebral salt wasting syndrome: are they different and does it matter?

verfasst von: Michael L. Moritz

Erschienen in: Pediatric Nephrology | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

The syndrome of inappropriate antidiudresis (SIAD) and cerebral salt wasting (CSW) are similar conditions with the main difference being the absence or presence of volume depletion. The two conditions may be indistinguishable at presentation, as volume status is difficult to assess, which can lead to under-diagnosis of CSW in patients with central nervous system (CNS) disease. Carefully conducted studies in patients with CNS disease have indicated that CSW may be more common than SIAD. CSW may be differentiated from SIAD based on the persistence of hypouricemia and increased fractional excretion of urate following the correction of hyponatremia. Hyponatremia should be prevented if possible and treated promptly when discovered in patients with CNS disease as even mild hyponatremia could lead to neurological deterioration. Fluid restriction should not be used for the prevention or treatment of hyponatremia in hospitalized patients with CNS disease as it could lead to volume depletion especially if CSW is present. 0.9% sodium chloride may not be sufficiently hypertonic for the prevention of hyponatremia in hospitalized patients with CNS disease and a more hypertonic fluid may be required. The preferred therapy for the treatment of hyponatremia in patients with CNS disease is 3% sodium chloride.
Literatur
2.
Zurück zum Zitat Rabinstein AA, Wijdicks EF (2003) Hyponatremia in critically ill neurological patients. Neurolog 9:290–300CrossRef Rabinstein AA, Wijdicks EF (2003) Hyponatremia in critically ill neurological patients. Neurolog 9:290–300CrossRef
3.
Zurück zum Zitat Maesaka JK, Imbriano LJ, Ali NM, Ilamathi E (2009) Is it cerebral or renal salt wasting? Kidney Int 76:934–938PubMedCrossRef Maesaka JK, Imbriano LJ, Ali NM, Ilamathi E (2009) Is it cerebral or renal salt wasting? Kidney Int 76:934–938PubMedCrossRef
4.
Zurück zum Zitat Bartter FC, Schwartz WB (1967) The syndrome of inappropriate secretion of antidiuretic hormone. Am J Med 42:790–806PubMedCrossRef Bartter FC, Schwartz WB (1967) The syndrome of inappropriate secretion of antidiuretic hormone. Am J Med 42:790–806PubMedCrossRef
5.
Zurück zum Zitat Decaux G, Musch W (2008) Clinical laboratory evaluation of the syndrome of inappropriate secretion of antidiuretic hormone. Clin J Am Soc Nephrol 3:1175–1184PubMedCrossRef Decaux G, Musch W (2008) Clinical laboratory evaluation of the syndrome of inappropriate secretion of antidiuretic hormone. Clin J Am Soc Nephrol 3:1175–1184PubMedCrossRef
6.
Zurück zum Zitat Southgate HJ, Burke BJ, Walters G (1992) Body space measurements in the hyponatraemia of carcinoma of the bronchus: evidence for the chronic 'sick cell' syndrome? Ann Clin Biochem 29:90–95PubMed Southgate HJ, Burke BJ, Walters G (1992) Body space measurements in the hyponatraemia of carcinoma of the bronchus: evidence for the chronic 'sick cell' syndrome? Ann Clin Biochem 29:90–95PubMed
7.
Zurück zum Zitat Cogan E, Debieve MF, Pepersack T, Abramow M (1988) Natriuresis and atrial natriuretic factor secretion during inappropriate antidiuresis. Am J Med 84:409–418PubMedCrossRef Cogan E, Debieve MF, Pepersack T, Abramow M (1988) Natriuresis and atrial natriuretic factor secretion during inappropriate antidiuresis. Am J Med 84:409–418PubMedCrossRef
8.
9.
Zurück zum Zitat Maesaka JK, Miyawaki N, Palaia T, Fishbane S, Durham JH (2007) Renal salt wasting without cerebral disease: diagnostic value of urate determinations in hyponatremia. Kidney Int 71:822–826PubMedCrossRef Maesaka JK, Miyawaki N, Palaia T, Fishbane S, Durham JH (2007) Renal salt wasting without cerebral disease: diagnostic value of urate determinations in hyponatremia. Kidney Int 71:822–826PubMedCrossRef
10.
Zurück zum Zitat Rivkees SA (2008) Differentiating appropriate antidiuretic hormone secretion, inappropriate antidiuretic hormone secretion and cerebral salt wasting: the common, uncommon, and misnamed. Curr Opin Pediatr 20:448–452PubMedCrossRef Rivkees SA (2008) Differentiating appropriate antidiuretic hormone secretion, inappropriate antidiuretic hormone secretion and cerebral salt wasting: the common, uncommon, and misnamed. Curr Opin Pediatr 20:448–452PubMedCrossRef
11.
Zurück zum Zitat Singh S, Bohn D, Carlotti AP, Cusimano M, Rutka JT, Halperin ML (2002) Cerebral salt wasting: truths, fallacies, theories, and challenges. Crit Care Med 30:2575–2579PubMedCrossRef Singh S, Bohn D, Carlotti AP, Cusimano M, Rutka JT, Halperin ML (2002) Cerebral salt wasting: truths, fallacies, theories, and challenges. Crit Care Med 30:2575–2579PubMedCrossRef
12.
Zurück zum Zitat Nelson PB, Seif SM, Maroon JC, Robinson AG (1981) Hyponatremia in intracranial disease: perhaps not the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). J Neurosurg 55:938–941PubMedCrossRef Nelson PB, Seif SM, Maroon JC, Robinson AG (1981) Hyponatremia in intracranial disease: perhaps not the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). J Neurosurg 55:938–941PubMedCrossRef
13.
Zurück zum Zitat Wijdicks EF, Vermeulen M, ten Haaf JA, Hijdra A, Bakker WH, van Gijn J (1985) Volume depletion and natriuresis in patients with a ruptured intracranial aneurysm. Ann Neurol 18:211–216PubMedCrossRef Wijdicks EF, Vermeulen M, ten Haaf JA, Hijdra A, Bakker WH, van Gijn J (1985) Volume depletion and natriuresis in patients with a ruptured intracranial aneurysm. Ann Neurol 18:211–216PubMedCrossRef
14.
Zurück zum Zitat Sivakumar V, Rajshekhar V, Chandy MJ (1994) Management of neurosurgical patients with hyponatremia and natriuresis. Neurosurgery 34:269–274, discussion 274PubMedCrossRef Sivakumar V, Rajshekhar V, Chandy MJ (1994) Management of neurosurgical patients with hyponatremia and natriuresis. Neurosurgery 34:269–274, discussion 274PubMedCrossRef
15.
Zurück zum Zitat Audibert G, Steinmann G, de Talance N, Laurens MH, Dao P, Baumann A, Longrois D, Mertes PM (2009) Endocrine response after severe subarachnoid hemorrhage related to sodium and blood volume regulation. Anesth Analg 108:1922–1928PubMedCrossRef Audibert G, Steinmann G, de Talance N, Laurens MH, Dao P, Baumann A, Longrois D, Mertes PM (2009) Endocrine response after severe subarachnoid hemorrhage related to sodium and blood volume regulation. Anesth Analg 108:1922–1928PubMedCrossRef
16.
Zurück zum Zitat Bussmann C, Bast T, Rating D (2001) Hyponatraemia in children with acute CNS disease: SIADH or cerebral salt wasting? Childs Nerv Syst 17:58–62, discussion 63PubMed Bussmann C, Bast T, Rating D (2001) Hyponatraemia in children with acute CNS disease: SIADH or cerebral salt wasting? Childs Nerv Syst 17:58–62, discussion 63PubMed
17.
Zurück zum Zitat Maesaka JK, Gupta S, Fishbane S (1999) Cerebral salt-wasting syndrome: does it exist? Nephron 82:100–109PubMedCrossRef Maesaka JK, Gupta S, Fishbane S (1999) Cerebral salt-wasting syndrome: does it exist? Nephron 82:100–109PubMedCrossRef
18.
Zurück zum Zitat Bitew S, Imbriano L, Miyawaki N, Fishbane S, Maesaka JK (2009) More on renal salt wasting without cerebral disease: response to saline infusion. Clin J Am Soc Nephrol 4:309–315PubMedCrossRef Bitew S, Imbriano L, Miyawaki N, Fishbane S, Maesaka JK (2009) More on renal salt wasting without cerebral disease: response to saline infusion. Clin J Am Soc Nephrol 4:309–315PubMedCrossRef
19.
Zurück zum Zitat Orbak Z, Kara IS (2010) Unusual complication in a child with lightning strike: cerebral salt wasting. Childs Nerv Syst 26:1125–1127PubMedCrossRef Orbak Z, Kara IS (2010) Unusual complication in a child with lightning strike: cerebral salt wasting. Childs Nerv Syst 26:1125–1127PubMedCrossRef
21.
Zurück zum Zitat Robertson GL (2006) Regulation of arginine vasopressin in the syndrome of inappropriate antidiuresis. Am J Med 119:S36–42PubMedCrossRef Robertson GL (2006) Regulation of arginine vasopressin in the syndrome of inappropriate antidiuresis. Am J Med 119:S36–42PubMedCrossRef
22.
Zurück zum Zitat Zerbe R, Stropes L, Robertson G (1980) Vasopressin function in the syndrome of inappropriate antidiuresis. Annu Rev Med 31:315–327PubMedCrossRef Zerbe R, Stropes L, Robertson G (1980) Vasopressin function in the syndrome of inappropriate antidiuresis. Annu Rev Med 31:315–327PubMedCrossRef
23.
Zurück zum Zitat Schrier RW, Gross P, Gheorghiade M, Berl T, Verbalis JG, Czerwiec FS, Orlandi C, Investigators SALT (2006) Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med 355:2099–2112PubMedCrossRef Schrier RW, Gross P, Gheorghiade M, Berl T, Verbalis JG, Czerwiec FS, Orlandi C, Investigators SALT (2006) Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med 355:2099–2112PubMedCrossRef
24.
Zurück zum Zitat Ghali JK, Koren MJ, Taylor JR, Brooks-Asplund E, Fan K, Long WA, Smith N (2006) Efficacy and safety of oral conivaptan: a V1A/V2 vasopressin receptor antagonist, assessed in a randomized, placebo-controlled trial in patients with euvolemic or hypervolemic hyponatremia. J Clin Endocrinol Metab 91:2145–2152PubMedCrossRef Ghali JK, Koren MJ, Taylor JR, Brooks-Asplund E, Fan K, Long WA, Smith N (2006) Efficacy and safety of oral conivaptan: a V1A/V2 vasopressin receptor antagonist, assessed in a randomized, placebo-controlled trial in patients with euvolemic or hypervolemic hyponatremia. J Clin Endocrinol Metab 91:2145–2152PubMedCrossRef
25.
Zurück zum Zitat Aronson D, Verbalis JG, Mueller M, Krum H (2011) Short- and long-term treatment of dilutional hyponatraemia with satavaptan, a selective arginine vasopressin V2-receptor antagonist: the DILIPO study. Eur J Heart Fail 13:327–336PubMedCrossRef Aronson D, Verbalis JG, Mueller M, Krum H (2011) Short- and long-term treatment of dilutional hyponatraemia with satavaptan, a selective arginine vasopressin V2-receptor antagonist: the DILIPO study. Eur J Heart Fail 13:327–336PubMedCrossRef
26.
Zurück zum Zitat Annane D, Decaux G, Smith N (2009) Efficacy and safety of oral conivaptan, a vasopressin-receptor antagonist, evaluated in a randomized, controlled trial in patients with euvolemic or hypervolemic hyponatremia. Am J Med Sci 337:28–36PubMedCrossRef Annane D, Decaux G, Smith N (2009) Efficacy and safety of oral conivaptan, a vasopressin-receptor antagonist, evaluated in a randomized, controlled trial in patients with euvolemic or hypervolemic hyponatremia. Am J Med Sci 337:28–36PubMedCrossRef
27.
Zurück zum Zitat Murphy T, Dhar R, Diringer M (2009) Conivaptan bolus dosing for the correction of hyponatremia in the neurointensive care unit. Neurocrit Care 11:14–19PubMedCrossRef Murphy T, Dhar R, Diringer M (2009) Conivaptan bolus dosing for the correction of hyponatremia in the neurointensive care unit. Neurocrit Care 11:14–19PubMedCrossRef
28.
Zurück zum Zitat Naidech AM, Paparello J, Liebling SM, Bassin SL, Levasseur K, Alberts MJ, Bernstein RA, Muro K (2010) Use of Conivaptan (Vaprisol) for hyponatremic neuro-ICU patients. Neurocrit Care 13:57–61PubMedCrossRef Naidech AM, Paparello J, Liebling SM, Bassin SL, Levasseur K, Alberts MJ, Bernstein RA, Muro K (2010) Use of Conivaptan (Vaprisol) for hyponatremic neuro-ICU patients. Neurocrit Care 13:57–61PubMedCrossRef
29.
Zurück zum Zitat Wright WL, Asbury WH, Gilmore JL, Samuels OB (2009) Conivaptan for hyponatremia in the neurocritical care unit. Neurocrit Care 11:6–13PubMedCrossRef Wright WL, Asbury WH, Gilmore JL, Samuels OB (2009) Conivaptan for hyponatremia in the neurocritical care unit. Neurocrit Care 11:6–13PubMedCrossRef
30.
Zurück zum Zitat Beck LH (1979) Hypouricemia in the syndrome of inappropriate secretion of antidiuretic hormone. N Engl J Med 301:528–530PubMedCrossRef Beck LH (1979) Hypouricemia in the syndrome of inappropriate secretion of antidiuretic hormone. N Engl J Med 301:528–530PubMedCrossRef
31.
Zurück zum Zitat Moritz ML, Ayus JC (2010) New aspects in the pathogenesis, prevention, and treatment of hyponatremic encephalopathy in children. Pediatr Nephrol 25:1225–1238PubMedCrossRef Moritz ML, Ayus JC (2010) New aspects in the pathogenesis, prevention, and treatment of hyponatremic encephalopathy in children. Pediatr Nephrol 25:1225–1238PubMedCrossRef
32.
Zurück zum Zitat Moritz ML, Ayus JC (2007) Hospital-acquired hyponatremia—why are hypotonic parenteral fluids still being used? Nat Clin Pract Nephrol 3:374–382PubMedCrossRef Moritz ML, Ayus JC (2007) Hospital-acquired hyponatremia—why are hypotonic parenteral fluids still being used? Nat Clin Pract Nephrol 3:374–382PubMedCrossRef
33.
Zurück zum Zitat McJunkin JE, de los Reyes EC, Irazuzta JE, Caceres MJ, Khan RR, Minnich LL, Fu KD, Lovett GD, Tsai T, Thompson A (2001) La Crosse encephalitis in children. N Engl J Med 344:801–807PubMedCrossRef McJunkin JE, de los Reyes EC, Irazuzta JE, Caceres MJ, Khan RR, Minnich LL, Fu KD, Lovett GD, Tsai T, Thompson A (2001) La Crosse encephalitis in children. N Engl J Med 344:801–807PubMedCrossRef
34.
35.
Zurück zum Zitat Hardesty DA, Sanborn MR, Parker WE, Storm PB (2011) Perioperative seizure incidence and risk factors in 223 pediatric brain tumor patients without prior seizures. J Neurosurg Pediatr 7:609–615PubMedCrossRef Hardesty DA, Sanborn MR, Parker WE, Storm PB (2011) Perioperative seizure incidence and risk factors in 223 pediatric brain tumor patients without prior seizures. J Neurosurg Pediatr 7:609–615PubMedCrossRef
36.
Zurück zum Zitat Moritz ML, Ayus JC (2003) Prevention of hospital-acquired hyponatremia: a case for using isotonic saline. Pediatrics 111:227–230PubMedCrossRef Moritz ML, Ayus JC (2003) Prevention of hospital-acquired hyponatremia: a case for using isotonic saline. Pediatrics 111:227–230PubMedCrossRef
37.
Zurück zum Zitat Jimenez R, Casado-Flores J, Nieto M, Garcia-Teresa MA (2006) Cerebral salt wasting syndrome in children with acute central nervous system injury. Pediatr Neurol 35:261–263PubMedCrossRef Jimenez R, Casado-Flores J, Nieto M, Garcia-Teresa MA (2006) Cerebral salt wasting syndrome in children with acute central nervous system injury. Pediatr Neurol 35:261–263PubMedCrossRef
38.
Zurück zum Zitat Moritz ML (2008) Urine sodium composition in ambulatory healthy children: hypotonic or isotonic? Pediatr Nephrol 23:955–957PubMedCrossRef Moritz ML (2008) Urine sodium composition in ambulatory healthy children: hypotonic or isotonic? Pediatr Nephrol 23:955–957PubMedCrossRef
39.
Zurück zum Zitat Neville KA, Sandeman DJ, Rubinstein A, Henry GM, McGlynn M, Walker JL (2010) Prevention of hyponatremia during maintenance intravenous fluid administration: a prospective randomized study of fluid type versus fluid rate. J Pediatr 156(313–319):e1–2PubMed Neville KA, Sandeman DJ, Rubinstein A, Henry GM, McGlynn M, Walker JL (2010) Prevention of hyponatremia during maintenance intravenous fluid administration: a prospective randomized study of fluid type versus fluid rate. J Pediatr 156(313–319):e1–2PubMed
40.
Zurück zum Zitat Sterns RH, Silver SM (2008) Cerebral salt wasting versus SIADH: what difference? J Am Soc Nephrol 19:194–196PubMedCrossRef Sterns RH, Silver SM (2008) Cerebral salt wasting versus SIADH: what difference? J Am Soc Nephrol 19:194–196PubMedCrossRef
41.
Zurück zum Zitat Wijdicks EF, Vermeulen M, Hijdra A, van Gijn J (1985) Hyponatremia and cerebral infarction in patients with ruptured intracranial aneurysms: is fluid restriction harmful? Ann Neurol 17:137–140PubMedCrossRef Wijdicks EF, Vermeulen M, Hijdra A, van Gijn J (1985) Hyponatremia and cerebral infarction in patients with ruptured intracranial aneurysms: is fluid restriction harmful? Ann Neurol 17:137–140PubMedCrossRef
42.
Zurück zum Zitat Moritz ML, Ayus JC (2010) 100 cc 3% sodium chloride bolus: a novel treatment for hyponatremic encephalopathy. Metab Brain Dis 25:91–96PubMedCrossRef Moritz ML, Ayus JC (2010) 100 cc 3% sodium chloride bolus: a novel treatment for hyponatremic encephalopathy. Metab Brain Dis 25:91–96PubMedCrossRef
Metadaten
Titel
Syndrome of inappropriate antidiuresis and cerebral salt wasting syndrome: are they different and does it matter?
verfasst von
Michael L. Moritz
Publikationsdatum
01.05.2012
Verlag
Springer-Verlag
Erschienen in
Pediatric Nephrology / Ausgabe 5/2012
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-012-2112-1

Weitere Artikel der Ausgabe 5/2012

Pediatric Nephrology 5/2012 Zur Ausgabe

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.